Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Réka, Gindele"'
Autor:
Zsuzsanna Bereczky, Réka Gindele, Szilvia Fiatal, Marianna Speker, Tünde Miklós, László Balogh, Zoltán Mezei, Zsuzsanna Szabó, Róza Ádány
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2021)
Background: Antithrombin (AT) is one of the most important regulator of hemostasis. AT Budapest 3 (ATBp3) is a prevalent type II heparin-binding site (IIHBS) deficiency due to founder effect. Thrombosis is a complex disease including arterial (ATE) a
Externí odkaz:
https://doaj.org/article/c8503f5cc9c94c6ba830f95bc1db18bb
Autor:
Tamás Major, Csaba Csobay-Novák, Réka Gindele, Zsuzsanna Szabó, László Bora, Natália Jóni, Tamás Rácz, Tamás Karosi, Zsuzsanna Bereczky
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Hereditary haemorrhagic telangiectasia (HHT; Osler–Weber–Rendu disease) is an autosomal dominant vascular disease characterized by nosebleeds, mucocutaneous telangiectases, visceral arteriovenous malformations (AVM) and a first-degree relative wi
Externí odkaz:
https://doaj.org/article/82f073717eab40d6a09c4c7607c71d6b
Autor:
Réka Gindele, Krisztina Pénzes-Daku, Gábor Balogh, Judit Kállai, Réka Bogáti, Bálint Bécsi, Ferenc Erdődi, Éva Katona, Zsuzsanna Bereczky
Publikováno v:
Biomolecules, Vol 11, Iss 4, p 544 (2021)
Antithrombin (AT) is a serine protease inhibitor, its activity is highly accelerated by heparin. Mutations at the heparin-binding region lead to functional defect, type II heparin-binding site (IIHBS) AT deficiency. The aim of this study was to inves
Externí odkaz:
https://doaj.org/article/f502af7ffe504ea482bb9d1edd87e030
Autor:
Réka Gindele, Adrienne Kerényi, Judit Kállai, György Pfliegler, Ágota Schlammadinger, István Szegedi, Tamás Major, Zsuzsanna Szabó, Zsuzsa Bagoly, Csongor Kiss, János Kappelmayer, Zsuzsanna Bereczky
Publikováno v:
Life, Vol 11, Iss 3, p 202 (2021)
Diagnosis of rare bleeding disorders is challenging and there are several differential diagnostics issues. Next-generation sequencing (NGS) is a useful tool to overcome these problems. The aim of this study was to demonstrate the usefulness of molecu
Externí odkaz:
https://doaj.org/article/701e79842d7344f49c5b1ac8c1499b3c
Autor:
Maria S Infante, Réka Gindele, Zsolt Oláh, Marianna Speker, Isabel Zuazu, Carlos Bravo-Pérez, Péter Ilonczai, Laura Entrena, José María Navarro García, Asunción Mora-Casado, María Eugenia de la Morena-Barrio, Antonia Miñano, José Padilla, Ágota Schlammadinger, Vicente Vicente, Belén de la Morena-Barrio, Zsuzsanna Bereczky, Javier Corral, Juan J Rodríguez-Sevilla, Rosa Cifuentes-Riquelme
Publikováno v:
American Journal of Hematology. 96:1363-1373
Atresia of inferior vena cava (IVC) is a rare congenital malformation associated with high risk of venous thrombosis that still has unknown etiology, although intrauterine IVC thrombosis has been suggested to be involved. The identification of IVC at
Autor:
Tamás Major, Zsuzsanna Bereczky, Réka Gindele, Gábor Balogh, Benedek Rácz, László Bora, Zsolt Kézsmárki, Boglárka Brúgós, György Pfliegler
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 3774, p 3774 (2021)
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 3774, p 3774 (2021)
Hereditary hemorrhagic telangiectasia (HHT) is a rare germline vascular malformation syndrome with a prevalence of 1:5000-1:10,000 [...].
Autor:
Gyula, Remenyi, Zsuzsanna, Bereczky, Réka, Gindele, Aniko, Ujfalusi, Arpad, Illes, Miklos, Udvardy
Publikováno v:
Pathology and Oncology Research
Increased red blood cell count may result from primary erythrocytosis (polycythemia vera), but it is often due to secondary causes with increased erythropoietin levels. Secondary erythrocytosis may also be congenital due to different gene mutations o
Autor:
László Bora, Natália Jóni, Péter Bárdossy, Zsuzsanna Kis, Tamás Rácz, Réka Gindele, Tamás Major, Tamás Karosi, Zsuzsanna Szabó, Zsuzsanna Bereczky
Publikováno v:
Orvosi Hetilap. 160:710-719
Abstract: Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multisystemic vascular disease with a worldwide prevalence of 1 : 5000 – 1 : 10 000. Diagnosis is based on clinical Curacao criteria. Approximately 85% of
Autor:
György Pfliegler, Ágota Schlammadinger, Zsuzsanna Bereczky, Réka Gindele, Erzsébet Marján, Ágnes Nagy, Anna Selmeczi, László Muszbek, Zsolt Oláh, László Nemes, Hajna Losonczy, Gábor Balogh, István Komáromi, Zoltán Boda, Péter Ilonczai, Katalin Rázsó, Mirjana Kovac, Gorana Mitic
Publikováno v:
Thrombosis Research. 160:119-128
Introduction Inherited antithrombin (AT) deficiency is a heterogeneous disease. Due to low prevalence, only a few studies are available concerning genotype-phenotype associations. The aim was to describe the clinical, laboratory and genetic character
Autor:
Tamás Major, Csaba Csobay-Novák, Réka Gindele, Zsuzsanna Szabó, László Bora, Natália Jóni, Tamás Rácz, Tamás Karosi, Zsuzsanna Bereczky
Publikováno v:
The Journal of International Medical Research
Journal of International Medical Research, Vol 48 (2020)
Journal of International Medical Research, Vol 48 (2020)
Hereditary haemorrhagic telangiectasia (HHT; Osler–Weber–Rendu disease) is an autosomal dominant vascular disease characterized by nosebleeds, mucocutaneous telangiectases, visceral arteriovenous malformations (AVM) and a first-degree relative wi